Ubiquitination of HEXIM1 by HDM2.

Détails

ID Serval
serval:BIB_E9EA4E0DE384
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Ubiquitination of HEXIM1 by HDM2.
Périodique
Cell Cycle
Auteur⸱e⸱s
Lau J., Lew Q.J., Diribarne G., Michels A.A., Dey A., Bensaude O., Lane D.P., Chao S.H.
ISSN
1551-4005[electronic], 1551-4005[linking]
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
8
Numéro
14
Pages
2247-2254
Langue
anglais
Résumé
Hexamethylene bis-acetamide inducible protein 1 (HEXIM1) is an inhibitor of the positive transcription elongation factor b (P-TEFb), which controls RNA polymerase II transcription and human immunodeficiency virus Tat transactivation. In cells, more than half of P-TEFb is associated with HEXIM1 resulting in the inactivation of P-TEFb. Recently, we found that nucleophosmin (NPM), a key factor involved in p53 signaling pathway, interacts with HEXIM1 and activates P-TEFb-dependent transcription. Here we report that human double minute-2 protein (HDM2), a p53-specific E3 ubiquitin ligase, specifically ubiquitinates HEXIM1 through the lysine residues located within the basic region of HEXIM1. However, the HDM2-induced HEXIM1 ubiquitination does not lead to proteasome-mediated protein degradation. Fusion of ubiquitin to HEXIM1 demonstrates stronger inhibition on P-TEFb-dependent transcription. Our results demonstrate that HDM2 functions as a specific E3 ubiquitin ligase for HEXIM1, suggesting a possible role for HEXIM1 ubiquitination in the regulation of P-TEFb activity.
Mots-clé
Cell Line, Cysteine Proteinase Inhibitors/pharmacology, Humans, Leupeptins/pharmacology, Nuclear Proteins/metabolism, Positive Transcriptional Elongation Factor B/genetics, Positive Transcriptional Elongation Factor B/metabolism, Proto-Oncogene Proteins c-mdm2/metabolism, RNA-Binding Proteins/metabolism, Signal Transduction, Tumor Suppressor Protein p53/metabolism, Ubiquitin-Protein Ligases/metabolism, Ubiquitination
Pubmed
Web of science
Création de la notice
15/05/2009 16:15
Dernière modification de la notice
20/08/2019 17:12
Données d'usage